![N~4~-[7-(1-benzofuran-2-yl)-1H-indazol-5-yl]pyrimidine-2,4-diamine in PDB entry 3kc3, assembly 2, side view.](https://www.ebi.ac.uk/pdbe/static/entry/3kc3_entity_2_side_image-200x200.png "Homo trimeric assembly 2 of PDB entry <span class='highlight'>3kc3</span> contains 3 copies of <span class='highlight'>N~4~-[7-(1-benzofuran-2-yl)-1H-indazol-5-yl]pyrimidine-2,4-diamine</span>. Side view.")
![N~4~-[7-(1-benzofuran-2-yl)-1H-indazol-5-yl]pyrimidine-2,4-diamine in PDB entry 3kc3, assembly 2, top view.](https://www.ebi.ac.uk/pdbe/static/entry/3kc3_entity_2_top_image-200x200.png "Homo trimeric assembly 2 of PDB entry <span class='highlight'>3kc3</span> contains 3 copies of <span class='highlight'>N~4~-[7-(1-benzofuran-2-yl)-1H-indazol-5-yl]pyrimidine-2,4-diamine</span>. Top view.")
Environment details NEW
MK2 500 bound to chain B
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.